Cargando…
Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
Patients at high risk for sudden cardiac death (SCD) may benefit from wearable cardioverter defibrillators (WCD) by avoiding immediate implantable cardioverter defibrillator (ICD) implantation. Different factors play an important role including patient selection, compliance and optimal drug treatmen...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881447/ https://www.ncbi.nlm.nih.gov/pubmed/35217697 http://dx.doi.org/10.1038/s41598-022-06007-y |
_version_ | 1784659467721244672 |
---|---|
author | El-Battrawy, Ibrahim Kovacs, Boldizsar Dreher, Tobias C. Klein, Norbert Rosenkaimer, Stephanie Röger, Susanne Kuschyk, Jürgen Saguner, Ardan Muammer Kowitz, Jacqueline Erath, Julia W. Duru, Firat Akin, Ibrahim |
author_facet | El-Battrawy, Ibrahim Kovacs, Boldizsar Dreher, Tobias C. Klein, Norbert Rosenkaimer, Stephanie Röger, Susanne Kuschyk, Jürgen Saguner, Ardan Muammer Kowitz, Jacqueline Erath, Julia W. Duru, Firat Akin, Ibrahim |
author_sort | El-Battrawy, Ibrahim |
collection | PubMed |
description | Patients at high risk for sudden cardiac death (SCD) may benefit from wearable cardioverter defibrillators (WCD) by avoiding immediate implantable cardioverter defibrillator (ICD) implantation. Different factors play an important role including patient selection, compliance and optimal drug treatment. We aimed to present real world data from 4 centers from Germany and Switzerland. Between 04/2012 and 03/2019, 708 patients were included in this registry. Patients were followed up over a mean time of 28 ± 35.5 months. Outcome data including gender differences and different etiologies of cardiomyopathy were analyzed. Out of 708 patients (81.8% males, mean age 61.0 ± 14.6), 44.6% of patients had non-ischemic cardiomyopathy, 39.8% ischemic cardiomyopathy, 7.9% myocarditis, 5.4% prior need for ICD explantation and 2.1% channelopathy. The mean wear time of WCD was 21.2 ± 4.3 h per day. In 46% of patients, left ventricular ejection fraction (LVEF) was > 35% during follow-up. The younger the patient was, the higher the LVEF and the lower the wear hours per day were. The total shock rate during follow-up was 2.7%. Whereas an appropriate WCD shock was documented in 16 patients (2.2%), 3 patients received an inappropriate ICD shock (0.5%). During follow-up, implantation of a cardiac implantable electronic device was carried out in 34.5% of patients. When comparing German patients (n = 516) to Swiss patients (n = 192), Swiss patients presented with longer wear days (70.72 ± 49.47 days versus 58.06 ± 40.45 days; p = 0.001) and a higher ICD implantation rate compared to German patients (48.4% versus 29.3%; p = 0.001), although LVEF at follow-up was similar between both groups. Young age is a negative independent predictor for the compliance in this large registry. The most common indication for WCD was non-ischemic cardiomyopathy followed by ischemic cardiomyopathy. The compliance rate was generally high with a decrease of wear hours per day at younger age. Slight differences were found between Swiss and German patients, which might be related to differences in mentality for ICD implantation. |
format | Online Article Text |
id | pubmed-8881447 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-88814472022-03-01 Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry El-Battrawy, Ibrahim Kovacs, Boldizsar Dreher, Tobias C. Klein, Norbert Rosenkaimer, Stephanie Röger, Susanne Kuschyk, Jürgen Saguner, Ardan Muammer Kowitz, Jacqueline Erath, Julia W. Duru, Firat Akin, Ibrahim Sci Rep Article Patients at high risk for sudden cardiac death (SCD) may benefit from wearable cardioverter defibrillators (WCD) by avoiding immediate implantable cardioverter defibrillator (ICD) implantation. Different factors play an important role including patient selection, compliance and optimal drug treatment. We aimed to present real world data from 4 centers from Germany and Switzerland. Between 04/2012 and 03/2019, 708 patients were included in this registry. Patients were followed up over a mean time of 28 ± 35.5 months. Outcome data including gender differences and different etiologies of cardiomyopathy were analyzed. Out of 708 patients (81.8% males, mean age 61.0 ± 14.6), 44.6% of patients had non-ischemic cardiomyopathy, 39.8% ischemic cardiomyopathy, 7.9% myocarditis, 5.4% prior need for ICD explantation and 2.1% channelopathy. The mean wear time of WCD was 21.2 ± 4.3 h per day. In 46% of patients, left ventricular ejection fraction (LVEF) was > 35% during follow-up. The younger the patient was, the higher the LVEF and the lower the wear hours per day were. The total shock rate during follow-up was 2.7%. Whereas an appropriate WCD shock was documented in 16 patients (2.2%), 3 patients received an inappropriate ICD shock (0.5%). During follow-up, implantation of a cardiac implantable electronic device was carried out in 34.5% of patients. When comparing German patients (n = 516) to Swiss patients (n = 192), Swiss patients presented with longer wear days (70.72 ± 49.47 days versus 58.06 ± 40.45 days; p = 0.001) and a higher ICD implantation rate compared to German patients (48.4% versus 29.3%; p = 0.001), although LVEF at follow-up was similar between both groups. Young age is a negative independent predictor for the compliance in this large registry. The most common indication for WCD was non-ischemic cardiomyopathy followed by ischemic cardiomyopathy. The compliance rate was generally high with a decrease of wear hours per day at younger age. Slight differences were found between Swiss and German patients, which might be related to differences in mentality for ICD implantation. Nature Publishing Group UK 2022-02-25 /pmc/articles/PMC8881447/ /pubmed/35217697 http://dx.doi.org/10.1038/s41598-022-06007-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article El-Battrawy, Ibrahim Kovacs, Boldizsar Dreher, Tobias C. Klein, Norbert Rosenkaimer, Stephanie Röger, Susanne Kuschyk, Jürgen Saguner, Ardan Muammer Kowitz, Jacqueline Erath, Julia W. Duru, Firat Akin, Ibrahim Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry |
title | Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry |
title_full | Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry |
title_fullStr | Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry |
title_full_unstemmed | Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry |
title_short | Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry |
title_sort | real life experience with the wearable cardioverter-defibrillator in an international multicenter registry |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881447/ https://www.ncbi.nlm.nih.gov/pubmed/35217697 http://dx.doi.org/10.1038/s41598-022-06007-y |
work_keys_str_mv | AT elbattrawyibrahim reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry AT kovacsboldizsar reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry AT drehertobiasc reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry AT kleinnorbert reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry AT rosenkaimerstephanie reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry AT rogersusanne reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry AT kuschykjurgen reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry AT sagunerardanmuammer reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry AT kowitzjacqueline reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry AT erathjuliaw reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry AT durufirat reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry AT akinibrahim reallifeexperiencewiththewearablecardioverterdefibrillatorinaninternationalmulticenterregistry |